Giriraj Pandey - National Institute for Pharmaceutical Education and Research

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 35 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Harnessing Electrospun Nanofibers for Comprehensive Oral Disease Management: Current Trends and Future Perspectives

Riya Gupta,Giriraj Pandey, Ajay Kumar,Anupriya Kapoor, Suraj Wagh,Tejaswini Kolipaka,Paras Famta, Alabhya Mishra,Saurabh Srivastava,Shashi Kiran Misra

Journal of Drug Delivery Science and Technologypp.106681, (2025)

引用0浏览0引用

Navigating the Brain: Harnessing Endogenous Cellular Hitchhiking for Targeting Neoplastic and Neuroinflammatory Diseases

Suraj S Wagh,Paras Famta,Saurabh Shah,Ganesh Vambhurkar,Giriraj Pandey,Anupama Sikder,Gurpreet Singh, Shalini Shukla, Abhishek Sharma, Sajja Bhanu Prasad,Akshay Shinde, Rahul Kumar, Nitin Pal Kalia, Rajeev Singh Raghuvanshi,Saurabh Srivastava

Asian journal of pharmaceutical sciencesno. 2 (2025): 101040-101040

引用0浏览0WOS引用

QbD Manoeuvred Niclosamide Laden Polylactic-co-Glycolic Acid Nanoparticles-Impregnated Gelatin Nanofibers for the Management of Oral Carcinoma

Saurabh Shah,Paras Famta, Rahul Kumar,Ganesh Vambhurkar,Giriraj Pandey,Akshay Shinde,Sajja Bhanu Prasad,Abhishek Sharma,Anamika Sharma,Shubham Kanaujiya,Dilip Kumar Arya,Tejaswini Kolipaka, Suraj Wagh,P. S. Rajinikanth,Saurabh Srivastava

BioNanoScienceno. 2 (2025): 1-16

引用0浏览0引用

Combating Breast Cancer-Associated Metastasis Using Paclitaxel and Tranilast-Loaded Human Serum Albumin Nanoparticles

Naitik Jain, Syed Shahrukh,Paras Famta,Saurabh Shah,Ganesh Vambhurkar, Dadi A Srinivasarao,Anamika Sharma,Giriraj Pandey, Suraj Wagh, Swapnil Shinde, Anjesh Khan, Prashanth Kumar,Saurabh Srivastava

Drug development and industrial pharmacypp.1-13, (2025)

引用0浏览0WOS引用

Exploring Advancements in Polysaccharide-Based Approaches: the Cornerstone of Next-Generation Cartilage Regeneration Therapeutics

Noella Abraham,Giriraj Pandey,Tejaswini Kolipaka, Mansi Negi,Dadi A Srinivasarao,Saurabh Srivastava

International journal of biological macromolecules（2025）

引用0浏览0WOS引用

Dual-ligand Functionalized Liposomes with Irgd/trastuzumab Co-Loaded with Gefitinib and Lycorine for Enhanced Metastatic Breast Cancer Therapy

Dilip Kumar Arya,Prashant Pandey, Anit Kumar,Kumarappan Chidambaram,Adel Al Fatease,Giriraj Pandey,Saurabh Srivastava,P. S. Rajinikanth

JOURNAL OF LIPOSOME RESEARCH (2025)

引用0浏览0WOS引用

Docetaxel and Niclosamide-loaded Nanofiber Systems for Improved Chemo-therapeutic Activity and Resistance Reversal in Prostate Cancer

Saurabh Shah,Paras Famta,Ganesh Vambhurkar, Rahul Kumar,Giriraj Pandey,Gurpreet Singh, Suraj Wagh,Shubham Kanaujiya,Dilip Kumar Arya,Abhishek Sharma,Akshay Shinde,Sajja Bhanu Prasad, Sachin Chandankar, Swapnil Shinde,Anamika Sharma,P. S. Rajinikanth,Dharmendra Kumar Khatri,Amit Asthana,Saurabh Srivastava

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACYno. 2 (2025): 132-143

引用0浏览0WOS引用

Nanoparticle-enhanced Delivery of Resveratrol for Targeted Therapy of Glioblastoma: Modulating the Akt/GSK-3β/NF-kB Pathway in C6 Glioma Cells

Gurpreet Singh,Paras Famta,Saurabh Shah,Ganesh Vambhurkar,Giriraj Pandey, Rahul Kumar,Prakash Kumar,Atul Mourya,Jitender Madan,Saurabh Srivastava,Dharmendra Kumar Khatri

BRAIN RESEARCH (2025)

引用0浏览0WOS引用

Harnessing Marine Antimicrobial Peptides for Novel Therapeutics: A Deep Dive into Ocean-Derived Bioactives

Kunal Agam Kanaujia, Suraj Wagh,Giriraj Pandey, Vivek Phatale,Pooja Khairnar,Tejaswini Kolipaka,P S Rajinikanth, Shubhini A Saraf,Saurabh Srivastava, Shailendra Kumar

International journal of biological macromoleculesno. Pt 3 (2025): 142158-142158

引用0浏览0WOS引用

Next-Generation Transformable Nanomedicines: Revolutionizing Cancer Drug Delivery and Theranostics

Swapnil Shinde,Saurabh Shah,Paras Famta, Suraj Wagh,Giriraj Pandey, Abhishek Sharma,Ganesh Vambhurkar, Akshita Jain,Saurabh Srivastava

Molecular pharmaceuticsno. 6 (2025): 2783-2806

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn